Greater weight loss promised by higher-dose Wegovy shot, now approved by FDA

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight ...

FDA warns biotech firm over cancer drug claims

The U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.

Chocolate sold nationwide recalled for containing erectile dysfunction drug

A chocolate product sold nationwide is being recalled after federal health officials discovered it contains a hidden ...

FDA says billionaire's claims about cancer drug Anktiva are misleading

Federal health officials posted a warning about misleading statements by biotech billionaire Dr. Patrick Soon-Shiong about ...
STAT

FDA approves Denali Therapeutics drug for Hunter syndrome

The FDA approved a new medicine from Denali Therapeutics for Hunter syndrome, a notable decision by the agency after a string ...

Trump administration's embattled FDA vaccine chief is leaving again

The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second ...

Hormone therapy boosts weight loss drug results by 35% in women, study finds

A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though experts urge caution on the findings.
University of California

Harnessing real-world data to bring life-saving drugs to the public sooner

UC Berkeley School of Public Health researchers are collaborating with the FDA and industry to make drug clinical trials ...

How to navigate the maze of drug discounts to get the best price

In February, TrumpRx joined a growing list of websites consumers can tap for discounts on their medicines. Here's a cheat sheet for getting the best deal.

Incyte's skin disease drug shows long-term symptom relief in late-stage trials

March 28 (Reuters) - Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in two late-stage trials. The company tested the drug, povorcitinib, in patients ...